Diagnóstico y tratamiento de la osteosarcopenia en pacientes geriátricos

Autores/as

DOI:

https://doi.org/10.33448/rsd-v13i12.47547

Palabras clave:

Osteosarcopenia; Diagnóstico; Tratamiento; Ancianos; Adultos mayores.

Resumen

La osteosarcopenia es un trastorno musculoesquelético en el que la masa ósea, la microarquitectura ósea, la masa muscular, la fuerza y el rendimiento disminuyen significativamente con la edad. La mayoría de los casos de osteosarcopenia son experimentados por la población anciana y sedentaria, así como por pacientes que tienen comorbilidades que afectan el sistema musculoesquelético o interfieren con la actividad física. El objetivo de este artículo es presentar un estudio sobre la osteosarcopenia en un paciente geriátrico. La osteoporosis representa un problema de salud importante que contribuye a millones de fracturas en todo el mundo, mientras que la sarcopenia está asociada con resultados metabólicos y el deterioro físico. Ambas enfermedades afectan la función física y social, la confianza y la calidad de vida de los pacientes. La osteosarcopenia es el término utilizado cuando ambas condiciones ocurren simultáneamente. Las interacciones entre ambas condiciones pueden acelerar la progresión de la enfermedad individual, lo que se asocia con una mayor morbilidad debido a caídas, fracturas, discapacidad y mortalidad.

Citas

Ardeljan, A. D., & Hurezeanu, R. (2022). Sarcopenia. IntechOpen. https://doi.org/10.5772/intechopen.98234.

Barnsley, J., Buckland, G., Chan, P. E., Ong, A., Ramos, A. S., Baxter, M., Beresford, L. S., Cooper, C., Dennison, E. M., & Howe, S. (2021). Pathophysiology and treatment of osteoporosis: Challenges for clinical practice in older people. Aging Clinical and Experimental Research, 33 (4), 759–73. https://doi.org/10.1007/s40520-021-01635-4.

Chen, L. K., Woo, J., Assantachai, P., Auyeung, T. W., Chou, M. Y., Iijima, K., & Arai, H. (2020). Asian Working Group for Sarcopenia: 2019 Consensus update on sarcopenia diagnosis and treatment. Journal of the American Medical Directors Association, 21(3), 300-7. e2. https://doi.org/10.1016/j.jamda.2019.12.024.

Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Landi, F., Martin, F. C., Michel, J. P., Rolland, Y., & Zamboni, M. (2019). Sarcopenia: Revised European consensus on definition and diagnosis. Age and Ageing, 48(4), 601–601. https://doi.org/10.1093/ageing/afz01.7

Daly, R. M., Gianoudis, J., Kersh, M. E., Bailey, C. A., Ebeling, P. R., Krug, R., van den Heuvel, E., & West, M. (2020). Effects of a 12-month supervised, community-based, multimodal exercise program followed by a 6-month research-to-practice transition on bone mineral density, trabecular microarchitecture, and physical function in older adults: A randomized controlled trial. Journal of Bone and Mineral Research, 35(3), 419–429. https://doi.org/10.1002/jbmr.3974.

Edwards, M. H., Gregson, C. L., Patel, H. P., Jameson, K. A., Harvey, N. C., Sayer, A. A., Dennison, E. M., & Cooper, C. (2013). Muscle size, strength, and physical performance and their associations with bone structure in the Hertfordshire Cohort Study. Journal of Bone and Mineral Research, 28(11), 2295–304. https://doi.org/10.1002/jbmr.1921.

Ferretti, J. L., Capozza, R. F., Cointry, G. R., García, S. L., Plotkin, H., Alvarez Filgueira, M. L., Bernini, E., Brunner, L., & Kausz, A. (1998). Gender-related differences in the relationship between densitometric values of whole-body bone mineral content and lean body mass in humans between 2 and 87 years of age. Bone, 22(6), 683–90. https://doi.org/10.1016/S8756-3282(98)00073-9.

Huang, C. F., Shiao, M. S., & Mao, T. Y. (2021). Retrospective study of the effects of zoledronic acid on muscle mass in osteoporosis patients. Drug Design, Development and Therapy, 15, 3711–5. https://doi.org/10.2147/DDDT.S322679.

Ilesanmi-Oyelere, B. L., Coad, J., Roy, N., & Kruger, M. C. (2018). Lean body mass in the prediction of bone mineral density in postmenopausal women. Biores Open Access, 7(1), 150–8. https://doi.org/10.1089/biores.2018.0023.

Intriago, M., Maldonado, G., Guerrero, R., Messina, O. D., & Rios, C. (2020). Bone mass loss and sarcopenia in Ecuadorian patients. Journal of Aging Research, 2020, 1–6. https://doi.org/10.1155/2020/4817037.

Johnell, O., & Kanis, J. A. (2006). An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporosis International, 17(12), 1726–33. https://doi.org/10.1007/s00198-006-0172-4.

Kirk, B., Mooney, K., Cousins, R., Angell, P., Jackson, M., Pugh, J. N., Price, A., & Cates, M. (2020). Effects of exercise and whey protein on muscle mass, fat mass, myoelectrical muscle fatigue and health-related quality of life in older adults: A secondary analysis of the Liverpool Hope University—Sarcopenia Ageing Trial (LHU-SAT). European Journal of Applied Physiology, 120 (2), 493–503. https://doi.org/10.1007/s00421-020-04374-6.

Leslie, W. D., Schousboe, J. T., Morin, S. N., Martineau, P., Lix, L. M., Johansson, H., Harvey, N. C., & Kanis, J. A. (2020). Loss in DXA-estimated total body lean mass but not fat mass predicts incident major osteoporotic fracture and hip fracture independently from FRAX: A registry-based cohort study. Archives of Osteoporosis, 15 (1), 96. https://doi.org/10.1007/s11657-020-00841-0.

Laskou, F., Patel, H. P., Cooper, C., & Dennison, E. (2022). A pas de deux of osteoporosis and sarcopenia: Osteosarcopenia. Climacteric, 25, 88–95. https://doi.org/10.1080/13697137.2022.2044770.

Locquet, M., Beaudart, C., Reginster, J. Y., & Bruyère, O. (2019). Association between the decline in muscle health and the decline in bone health in older individuals from the SarcoPhAge cohort. Calcified Tissue International, 104(3), 273–284. https://doi.org/10.1007/s00223-019-00491-x.

Maggi, S., & Falaschi, P. (2022). Orthogeriatrics: The management of older patients with fragility fractures (2nd ed.). Springer. https://doi.org/10.1007/978-3-030-61119-3.

Paintin, J., Cooper, C., & Dennison, E. (2018). Osteosarcopenia. British Journal of Hospital Medicine, 79(5), 253–8. https://doi.org/10.12968/hmed.2018.79.5.253.

Pereira A. S. et al. (2018). Metodologia da pesquisa científica. [free e-book]. Santa Maria/RS. Ed. UAB/NTE/UFSM.

Pizzonia, M., Casabella, A., Natali, M., Petrocchi, L., Carmisciano, L., Nencioni, A., Giusti, A., & Ferrone, F. (2021). Osteosarcopenia in very old age adults after hip fracture: A real-world therapeutic standpoint. Frontiers in Medicine, 8, 682013. https://doi.org/10.3389/fmed.2021.682013.

Polito, A., Barnaba, L., Ciarapica, D., & Azzini, E. (2022). Osteosarcopenia: A narrative review on clinical studies. International Journal of Molecular Sciences, 23(24), 8343. https://doi.org/10.3390/ijms23248343.

Rizzoli, R., Stevenson, J. C., Bauer, J. M., van Loon, L. J. C., Walrand, S., Kanis, J. A., & Reginster, J. Y. (2014). The role of dietary protein and vitamin D in maintaining musculoskeletal health in postmenopausal women: A consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Maturitas, 79(1), 122–32. https://doi.org/10.1016/j.maturitas.2014.07.005.

Rosenberg, I. H. (2011). Sarcopenia: Origins and clinical relevance. Clinical Geriatrics Medicine, 27(3), 337–339. https://doi.org/10.1016/j.cger.2011.03.002.

Toassi, R. F. C. & Petry, P. C. (2021). Metodologia científica aplicada à área da Saúde. (2ed.). Editora da UFRGS.

Vinícius-Souza, G. E., Noll, M., & Silveira, E. A. (2021). Effectiveness of exercise for osteosarcopenia in older adults: A systematic review protocol. BMJ Open, 11(11), e047671. https://doi.org/10.1136/bmjopen-2021-047671.

Descargas

Publicado

26/11/2024

Cómo citar

NUGRAHA, P. P. P. .; PURNAMI, N. K. R. Diagnóstico y tratamiento de la osteosarcopenia en pacientes geriátricos. Research, Society and Development, [S. l.], v. 13, n. 12, p. e08131247547, 2024. DOI: 10.33448/rsd-v13i12.47547. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/47547. Acesso em: 7 ene. 2025.

Número

Sección

Ciencias de la salud